Literature DB >> 24271122

Synthesis and pharmacological characterization of fluorescent opioid receptor probes.

V M Kolb1, A D Koman, A Neil.   

Abstract

A series of five fluorescent opioid receptor probes was synthesized by coupling naloxone, oxymorphone or naltrexone with fluorescein or tetramethylrhodamine B. The series was characterized for capacity to displace (3)H-dihydromorphine from rat brain opioid receptors. All compounds showed receptor binding, and 1-(N)-fluoresceinyl naltrexone thiosemicarbazone displayed the highest mu-receptor affinity with a Ki value of 3 nM. l-(N)-fluoresceinyl naloxone thiosemicarbazone was a morphine antagonist in vivo, approximately 6 % as potent as naloxone and naloxonazine in the mouse hot-plate test.

Entities:  

Year:  1985        PMID: 24271122     DOI: 10.1023/A:1016385416294

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.

Authors:  N Chatterjie; C E Inturrisi
Journal:  J Med Chem       Date:  1975-05       Impact factor: 7.446

2.  Fluorescent and photo-affinity enkephalin derivatives: preparation and interaction with opiate receptors.

Authors:  E Hazum; K J Chang; Y Shechter; S Wilkinson; P Cuatrecasas
Journal:  Biochem Biophys Res Commun       Date:  1979-06-13       Impact factor: 3.575

3.  Fluorescent enkephalin derivatives with biological activity.

Authors:  M C Fournie-Zaluski; G Gacel; B P Roques; B Senault; J M Lecomte; B Malfroy; J P Swerts; J C Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1978-07-14       Impact factor: 3.575

4.  Detection and characterization of four binding sites for opioids in the mouse brain.

Authors:  A Neil
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1985-02

5.  Study of the syn and anti isomerism of the long-lasting opiate antagonist naloxazone and related compounds.

Authors:  V M Kolb; J R Gober
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

6.  Separation of morphine analgesia from physical dependence.

Authors:  G S Ling; J M MacLeod; S Lee; S H Lockhart; G W Pasternak
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

7.  Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.

Authors:  E F Hahn; M Carroll-Buatti; G W Pasternak
Journal:  J Neurosci       Date:  1982-05       Impact factor: 6.167

8.  Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.

Authors:  G W Pasternak; E F Hahn
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

9.  Estrogen receptor cytochemistry by fluorescent estrogen.

Authors:  I Nenci; W B Dandliker; C Y Meyers; E Marchetti; A Marzola; G Fabris
Journal:  J Histochem Cytochem       Date:  1980-10       Impact factor: 2.479

10.  Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates. Heterogeneity in opioid mechanisms indicated.

Authors:  A Neil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

View more
  2 in total

1.  Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation.

Authors:  A Koman; M Einarsson; L Terenius
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

2.  Prolonged receptor blockade by opioid receptor probes.

Authors:  A Koman; V M Kolb; L Terenius
Journal:  Pharm Res       Date:  1986-02       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.